MedPath

Influence of FSH/LH Ratio in Controlled Ovarian Stimulation

Early Phase 1
Completed
Conditions
Sub-Fertility
Interventions
Drug: FSH/LH
Registration Number
NCT02994550
Lead Sponsor
Hospital de Cruces
Brief Summary

The aim of this study is to compare different FSH/LH ratios in controlled ovarian stimulation

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
447
Inclusion Criteria
  • Patients undergoing IVF cycles in Cruces University Hospital.
  • Signed IVF and cryopreservation informed consent.
  • Age >35 and <40 years.
  • FSH levels <10 mIU/ml.
Exclusion Criteria
  • When inclusion criteria are not fulfilled

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FSH/LH 4/1FSH/LHdose: 300IU FSHrec and 75IU LHrec
FSH/LH 2/1FSH/LHdose: 300IU FSHrec and 150IU LHrec
Primary Outcome Measures
NameTimeMethod
Pregnancy achievement3 months after drug administration

To report our results in terms of pregnancy per embryo transfer

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.